The global insulin market size is estimated at USD 29.73 billion in 2024, grew to USD 33.81 billion in 2025 and is predicted to surpass around USD 107.36 billion by 2034, expanding at a CAGR of 13.70% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Insulin Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Insulin Market Revenue and Volume Forecast, by Product, 2024-2034
8.1.1. Rapid-Acting Insulin
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Long-Acting Insulin
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Combination Insulin
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Biosimilar
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Insulin Market Revenue and Volume Forecast, by Application, 2024-2034
9.1.1. Human Insulin
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Insulin Analog
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Insulin Market Revenue and Volume Forecast, by Type, 2024-2034
10.1.1. Type 1 Diabetes Mellitus
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Type 2 Diabetes Mellitus
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Insulin Market Revenue and Volume Forecast, by Distribution Channel, 2024-2034
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Others
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
13.1. Novo Nordisk A/S
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Sanofi S.A.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Eli Lilly and Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck & Co., Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Biocon Limited
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Pfizer Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Johnson & Johnson
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Roche Holding AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. AstraZeneca PLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Boehringer Ingelheim International GmbH
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample